Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose rifapentine and quinolone trial for pulmonary tuberculosis
PACTR2008060000861040Completed
- Sponsor
- St George's, University of London
- Start
- Jul 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 4
01
Overview
Trial of rifapentine and moxifloxacin in pulmonary tuberculosis (TB) (2 arms), sponsored by St George's, University of London. Started Jul 2007; status: completed.
02
Drugs
rifapentinemoxifloxacin
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on PACTR2008060000861040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR2008060000861040.